Lv1
46 积分 2025-10-05 加入
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
10小时前
已完结
Association between metabolic multimorbidity and the risk of cardiovascular disease, kidney disease, and mortality: longitudinal evidence from CHARLS (2011–2020)
13天前
已完结
New drugs: where did we go wrong and what can we do better?
17天前
已完结
Long-term lessons from EMPA-KIDNEY
3个月前
已完结
Diuretics in patients with chronic kidney disease
3个月前
已完结
A multicenter randomized controlled trial in patients with type 2 diabetes mellitus to evaluate an "advanced pharmaceutical care" intervention for the prevention of adverse effects and drug-related problems in a follow-uphome visit (BayPharmCareDiabetesTrail)
3个月前
已关闭
Efficacy and Safety of Rosuvastatin/Amlodipine FDC in Patients With Hypertension and Dyslipidemia: A Multicenter, Prospective, Observational Study
3个月前
已完结
Tolerability of Dipeptidyl Peptidase-4 Inhibitors: A Review
3个月前
已完结
Characteristic analysis of adverse reactions to natural and synthetic alpha-glucosidase inhibitors: a descriptive analysis using World Health Organisation-VigiAccess
3个月前
已关闭
Safety and Tolerability of Glucagon-Like Peptide-1 Receptor Agonists: A State-of-the-Art Narrative Review
3个月前
已完结
皖公网安备34019202002308
